Florian Deuschl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Florian Deuschl has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
Johannes Schirmer
10 shared publications- Niklas Schofer
Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Germany (N.S.).
10 shared publications - Ulrich Schäfer
Department of Cardiology, University Heart Center, Hamburg, Germany
10 shared publications - Hermann Reichenspurner
Department of Cardiovascular Surgery, University Heart and Vascular Center Hamburg, Martinistraße 52, 20246 Hamburg, Germany
9 shared publications - Lenard Conradi
Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
9 shared publications - Stefan Blankenberg
Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
9 shared publications
Latest Publications
- 20 February 2023
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 16 (4) , S90
CRT-700.24 Comparison of a Novel Self-Expanding Transcatheter Heart Valve with Two Established Devices for Treatment of Degenerated Surgical Aortic Bioprostheses
- 20 February 2023
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 16 (4) , S90
CRT-700.24 Comparison of a Novel Self-Expanding Transcatheter Heart Valve with Two Established Devices for Treatment of Degenerated Surgical Aortic Bioprostheses
- Open Access
- 10 August 2022
- Published by Elsevier in Structural Heart
- Vol. 6 (4) , 100071
Three-Dimensional Intracardiac Echocardiography for Tricuspid Transcatheter Edge-to-Edge Repair
- 10 August 2022
- Published by Elsevier in Structural Heart
- Vol. 6 (4) , 100071
Open AccessThree-Dimensional Intracardiac Echocardiography for Tricuspid Transcatheter Edge-to-Edge Repair
- 30 September 2019
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 56 (6) , 1131-1139
Transcatheter aortic valve implantation versus surgical aortic valve replacement in low-risk patients: a propensity score-matched analysis
OBJECTIVES: The aim of the study was to determine the differences in outcomes of surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI) in low-risk patients. METHODS: All patients with a logistic EuroSCORE II <4% who underwent transfemoral TAVI between 2008 and 2016 (n = 955) or SAVR between 2009 and 2014 (n = 886) at our centre were included. One hundred and nine patients per group were available for propensity score matching. RESULTS: Mortality during the 30-day follow-up showed no differences (SAVR vs TAVI: 1.1% vs 1.8%, P = 1.0) but the rates of permanent pacemaker implantation (0.0 vs 14.8%, P < 0.001) and paravalvular leakage ≥ moderate (0.0 vs 7.0%, P = 0.017) were higher in TAVI patients. No difference was found regarding postoperative effective orifice area and transvalvular pressure gradients. Although, the 1-year survival was similar between both groups; 3- and 5-year survival was significantly inferior in the TAVI patient cohort. CONCLUSIONS: TAVI yielded similar short-term outcomes compared with SAVR despite higher rates of permanent pacemaker implantation and paravalvular leakage ≥ moderate, but inferior long-term survival. Poorer long-term outcomes of the TAVI patient cohort were attributable to a more comorbid TAVI population. This emphasizes the need for long-term results from randomized controlled trials before TAVI can be broadly expanded to younger low-risk patients.
- 30 September 2019
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 56 (6) , 1131-1139
Transcatheter aortic valve implantation versus surgical aortic valve replacement in low-risk patients: a propensity score-matched analysis
OBJECTIVES: The aim of the study was to determine the differences in outcomes of surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI) in low-risk patients. METHODS: All patients with a logistic EuroSCORE II <4% who underwent transfemoral TAVI between 2008 and 2016 (n = 955) or SAVR between 2009 and 2014 (n = 886) at our centre were included. One hundred and nine patients per group were available for propensity score matching. RESULTS: Mortality during the 30-day follow-up showed no differences (SAVR vs TAVI: 1.1% vs 1.8%, P = 1.0) but the rates of permanent pacemaker implantation (0.0 vs 14.8%, P < 0.001) and paravalvular leakage ≥ moderate (0.0 vs 7.0%, P = 0.017) were higher in TAVI patients. No difference was found regarding postoperative effective orifice area and transvalvular pressure gradients. Although, the 1-year survival was similar between both groups; 3- and 5-year survival was significantly inferior in the TAVI patient cohort. CONCLUSIONS: TAVI yielded similar short-term outcomes compared with SAVR despite higher rates of permanent pacemaker implantation and paravalvular leakage ≥ moderate, but inferior long-term survival. Poorer long-term outcomes of the TAVI patient cohort were attributable to a more comorbid TAVI population. This emphasizes the need for long-term results from randomized controlled trials before TAVI can be broadly expanded to younger low-risk patients.
- 9 September 2018
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 92 (7) , E481-E485
Valve‐in‐valve‐in‐valve: Balloon expandable transcatheter heart valve in failing self‐expandable transcatheter heart valve in deteriorated surgical bioprosthesis
Valve‐in‐valve (ViV) procedures for failing bioprostheses carry a certain risk for device malfunction. We herein report a case of a failing Evolut R in a deteriorated Mitroflow, treated with a Sapien 3.An 81 year old female patient received surgical aortic valve replacement and was treated by ViV due to deterioration. Three years later, echocardiography revealed a pressure gradient of peak/mean 105/63 mmHg. Subsequently, a second ViV procedure with initial intentional rupture of the bioprosthetic stent was performed. Immediate stent recoil of the Evolut R prompted implantation of a Sapien 3. In 30‐day follow‐up, mean pressure gradient of 30 mmHg and nearly complete symptom relief was documented.Fracture of a surgical bioprosthetic stent is feasible in a ViV configuration. Supra‐annular placement of a balloon‐expandable THV as ViV‐in‐valve is feasible with suboptimal hemodynamic results in this case. Risk of re‐do surgery should be weighted against anticipated hemodynamic and clinical results.
- 9 September 2018
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 92 (7) , E481-E485
Valve‐in‐valve‐in‐valve: Balloon expandable transcatheter heart valve in failing self‐expandable transcatheter heart valve in deteriorated surgical bioprosthesis
Valve‐in‐valve (ViV) procedures for failing bioprostheses carry a certain risk for device malfunction. We herein report a case of a failing Evolut R in a deteriorated Mitroflow, treated with a Sapien 3.An 81 year old female patient received surgical aortic valve replacement and was treated by ViV due to deterioration. Three years later, echocardiography revealed a pressure gradient of peak/mean 105/63 mmHg. Subsequently, a second ViV procedure with initial intentional rupture of the bioprosthetic stent was performed. Immediate stent recoil of the Evolut R prompted implantation of a Sapien 3. In 30‐day follow‐up, mean pressure gradient of 30 mmHg and nearly complete symptom relief was documented.Fracture of a surgical bioprosthetic stent is feasible in a ViV configuration. Supra‐annular placement of a balloon‐expandable THV as ViV‐in‐valve is feasible with suboptimal hemodynamic results in this case. Risk of re‐do surgery should be weighted against anticipated hemodynamic and clinical results.
- 1 June 2018
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 11 (12) , 1129-1130
Tricuspid Valve Regurgitation
- 1 June 2018
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 11 (12) , 1129-1130
Tricuspid Valve Regurgitation